BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 27437826)

  • 1. First-in-Human Trial of MIV-150 and Zinc Acetate Coformulated in a Carrageenan Gel: Safety, Pharmacokinetics, Acceptability, Adherence, and Pharmacodynamics.
    Friedland BA; Hoesley CJ; Plagianos M; Hoskin E; Zhang S; Teleshova N; Alami M; Novak L; Kleinbeck KR; Katzen LL; Zydowsky TM; Fernández-Romero JA; Creasy GW
    J Acquir Immune Defic Syndr; 2016 Dec; 73(5):489-496. PubMed ID: 27437826
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In Vitro Exposure to PC-1005 and Cervicovaginal Lavage Fluid from Women Vaginally Administered PC-1005 Inhibits HIV-1 and HSV-2 Infection in Human Cervical Mucosa.
    Villegas G; Calenda G; Zhang S; Mizenina O; Kleinbeck K; Cooney ML; Hoesley CJ; Creasy GW; Friedland B; Fernández-Romero JA; Zydowsky TM; Teleshova N
    Antimicrob Agents Chemother; 2016 Sep; 60(9):5459-66. PubMed ID: 27381393
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A MIV-150/zinc acetate gel inhibits SHIV-RT infection in macaque vaginal explants.
    Barnable P; Calenda G; Ouattara L; Gettie A; Blanchard J; Jean-Pierre N; Kizima L; Rodríguez A; Abraham C; Menon R; Seidor S; Cooney ML; Roberts KD; Sperling R; Piatak M; Lifson JD; Fernandez-Romero JA; Zydowsky TM; Robbiani M; Teleshova N
    PLoS One; 2014; 9(9):e108109. PubMed ID: 25259616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel intravaginal ring to prevent HIV-1, HSV-2, HPV, and unintended pregnancy.
    Ugaonkar SR; Wesenberg A; Wilk J; Seidor S; Mizenina O; Kizima L; Rodriguez A; Zhang S; Levendosky K; Kenney J; Aravantinou M; Derby N; Grasperge B; Gettie A; Blanchard J; Kumar N; Roberts K; Robbiani M; Fernández-Romero JA; Zydowsky TM
    J Control Release; 2015 Sep; 213():57-68. PubMed ID: 26091920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An antiretroviral/zinc combination gel provides 24 hours of complete protection against vaginal SHIV infection in macaques.
    Kenney J; Aravantinou M; Singer R; Hsu M; Rodriguez A; Kizima L; Abraham CJ; Menon R; Seidor S; Chudolij A; Gettie A; Blanchard J; Lifson JD; Piatak M; Fernández-Romero JA; Zydowsky TM; Robbiani M
    PLoS One; 2011 Jan; 6(1):e15835. PubMed ID: 21246052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Zinc acetate/carrageenan gels exhibit potent activity in vivo against high-dose herpes simplex virus 2 vaginal and rectal challenge.
    Fernández-Romero JA; Abraham CJ; Rodriguez A; Kizima L; Jean-Pierre N; Menon R; Begay O; Seidor S; Ford BE; Gil PI; Peters J; Katz D; Robbiani M; Zydowsky TM
    Antimicrob Agents Chemother; 2012 Jan; 56(1):358-68. PubMed ID: 22064530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The nonnucleoside reverse transcriptase inhibitor MIV-150 in carrageenan gel prevents rectal transmission of simian/human immunodeficiency virus infection in macaques.
    Singer R; Derby N; Rodriguez A; Kizima L; Kenney J; Aravantinou M; Chudolij A; Gettie A; Blanchard J; Lifson JD; Piatak M; Fernández-Romero JA; Zydowsky TM; Robbiani M
    J Virol; 2011 Jun; 85(11):5504-12. PubMed ID: 21411526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An intravaginal ring that releases three antiviral agents and a contraceptive blocks SHIV-RT infection, reduces HSV-2 shedding, and suppresses hormonal cycling in rhesus macaques.
    Derby N; Aravantinou M; Kenney J; Ugaonkar SR; Wesenberg A; Wilk J; Kizima L; Rodriguez A; Zhang S; Mizenina O; Levendosky K; Cooney ML; Seidor S; Gettie A; Grasperge B; Blanchard J; Piatak M; Lifson JD; Fernández-Romero J; Zydowsky TM; Robbiani M
    Drug Deliv Transl Res; 2017 Dec; 7(6):840-858. PubMed ID: 28600625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A single dose of a MIV-150/Zinc acetate gel provides 24 h of protection against vaginal simian human immunodeficiency virus reverse transcriptase infection, with more limited protection rectally 8-24 h after gel use.
    Kenney J; Singer R; Derby N; Aravantinou M; Abraham CJ; Menon R; Seidor S; Zhang S; Gettie A; Blanchard J; Piatak M; Lifson JD; Fernández-Romero JA; Zydowsky TM; Robbiani M
    AIDS Res Hum Retroviruses; 2012 Nov; 28(11):1476-84. PubMed ID: 22737981
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and pharmacokinetics of single, dual, and triple antiretroviral drug formulations delivered by pod-intravaginal rings designed for HIV-1 prevention: A Phase I trial.
    Vincent KL; Moss JA; Marzinke MA; Hendrix CW; Anton PA; Pyles RB; Guthrie KM; Dawson L; Olive TJ; Butkyavichene I; Churchman SA; Cortez JM; Fanter R; Gunawardana M; Miller CS; Yang F; Rosen RK; Vargas SE; Baum MM
    PLoS Med; 2018 Sep; 15(9):e1002655. PubMed ID: 30265679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Results of a phase 1, randomized, placebo-controlled first-in-human trial of griffithsin formulated in a carrageenan vaginal gel.
    Teleshova N; Keller MJ; Fernández Romero JA; Friedland BA; Creasy GW; Plagianos MG; Ray L; Barnable P; Kizima L; Rodriguez A; Cornejal N; Melo C; Cruz Rodriguez G; Mukhopadhyay S; Calenda G; Sinkar SU; Bonnaire T; Wesenberg A; Zhang S; Kleinbeck K; Palmer K; Alami M; O'Keefe BR; Gillevet P; Hur H; Liang Y; Santone G; Fichorova RN; Kalir T; Zydowsky TM
    PLoS One; 2022; 17(1):e0261775. PubMed ID: 35051209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MIV-150 and zinc acetate combination provides potent and broad activity against HIV-1.
    Mizenina O; Hsu M; Jean-Pierre N; Aravantinou M; Levendosky K; Paglini G; Zydowsky TM; Robbiani M; Fernández-Romero JA
    Drug Deliv Transl Res; 2017 Dec; 7(6):859-866. PubMed ID: 28812250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety, acceptability, and pharmacokinetics of a monoclonal antibody-based vaginal multipurpose prevention film (MB66): A Phase I randomized trial.
    Politch JA; Cu-Uvin S; Moench TR; Tashima KT; Marathe JG; Guthrie KM; Cabral H; Nyhuis T; Brennan M; Zeitlin L; Spiegel HML; Mayer KH; Whaley KJ; Anderson DJ
    PLoS Med; 2021 Feb; 18(2):e1003495. PubMed ID: 33534791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PRO 2000 gel inhibits HIV and herpes simplex virus infection following vaginal application: a double-blind placebo-controlled trial.
    Keller MJ; Zerhouni-Layachi B; Cheshenko N; John M; Hogarty K; Kasowitz A; Goldberg CL; Wallenstein S; Profy AT; Klotman ME; Herold BC
    J Infect Dis; 2006 Jan; 193(1):27-35. PubMed ID: 16323128
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multipurpose Prevention Approaches with Antiretroviral-Based Formulations.
    Jean-Pierre N; Barnable P; Kizima L; Rodríguez A; Seidor S; Cooney ML; Clark MR; Doncel GF; Robbiani M; Zydowsky TM; Teleshova N; Fernández-Romero JA
    Antimicrob Agents Chemother; 2016 Feb; 60(2):1141-4. PubMed ID: 26596943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carrageenan/MIV-150 (PC-815), a combination microbicide.
    Fernández-Romero JA; Thorn M; Turville SG; Titchen K; Sudol K; Li J; Miller T; Robbiani M; Maguire RA; Buckheit RW; Hartman TL; Phillips DM
    Sex Transm Dis; 2007 Jan; 34(1):9-14. PubMed ID: 16924181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Novel Microbicide/Contraceptive Intravaginal Ring Protects Macaque Genital Mucosa against SHIV-RT Infection Ex Vivo.
    Villegas G; Calenda G; Ugaonkar S; Zhang S; Kizima L; Mizenina O; Gettie A; Blanchard J; Cooney ML; Robbiani M; Fernández-Romero JA; Zydowsky TM; Teleshova N
    PLoS One; 2016; 11(7):e0159332. PubMed ID: 27428377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Colposcopic evaluation of a vaginal gel formulation of iota-carrageenan.
    Elias CJ; Coggins C; Alvarez F; Brache V; Fraser IS; Lacarra M; Lähteenmäki P; Massai R; Mishell DR; Phillips DM; Salvatierra AM
    Contraception; 1997 Dec; 56(6):387-9. PubMed ID: 9494773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acceptability of a carrageenan-based candidate vaginal microbicide and matching placebo: findings from a phase II safety trial among women in Chiang Rai, Thailand.
    Jones HE; Chaikummao S; van de Wijgert JH; Friedland BA; Manopaiboon C; Witwatwongwana P; Wankrairot M; Chantharojwong N; Kilmarx PH
    J Womens Health (Larchmt); 2009 Jul; 18(7):1003-10. PubMed ID: 19575689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of Sex on the Pharmacokinetics and Pharmacodynamics of 1% Tenofovir Gel.
    Herold BC; Chen BA; Salata RA; Marzinke MA; Kelly CW; Dezzutti CS; McGowan I; Galaska B; Levy L; Piper JM; Hillier S; Hendrix CW
    Clin Infect Dis; 2016 Feb; 62(3):375-382. PubMed ID: 26508513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.